The State of Myeloproliferative Neoplasms (MPNs)

Shared insight on the current treatment landscape for myeloproliferative neoplasms (MPNs), including novel therapies for essential thrombocythemia (ET), polycythemia vera (PV), and myelofibrosis (MF).